Little House Capital LLC Gilead Sciences, Inc. Transaction History

Little House Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $528,114 - $661,784	-9,118 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$64.88 - $73.64 $64,815 - $73,566	999 Added 12.3%	9,118 $662,000
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $78,452 - $84,641	1,159 Added 16.65%	8,119 $567,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $441,751 - $482,675	6,960 New	6,960 $479,000
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $40,834 - $45,790	-660 Closed	0 $0

Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $41,269 - $46,233	660 New	660 $42,000

1,885

8.71M

8.02M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $83.6B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Little House Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Little House Capital LLC with notifications on news.